Czyzyk A, Lawecki J, Rogala H, Malczewski B, Kowalski H
Diabetologia. 1975 Apr;11(2):125-8. doi: 10.1007/BF00429835.
Twenty-one patients with mild maturity-onset diabetes were given introduodenal infusions of an amino acid mixture (0.5 g amino acids per kg body weight). In 9 other patients L-arginine was infused intravenously in a constant dose of 25 g. Alpha-amino nitrogen, blood glucose and plasma insulin levels were assayed under control conditions and after three days of treatment with phenformin, 150 mg daily, plus the same 150 mg dose 60 min before the second loading. Intraduodenal infusion of the amino acid mixture provoked a greater increase in plasma insulin than intravenous infusion of L-arginine, this increase being significantly inhibited by phenformin only in the first case. Since no evident influence of phenformin on the intestinal absorption of amino acids could be demonstrated, this effect may be explained by a local action on the intestinal wall exposed to high concentrations of the drug, resulting in the inhibition of the insulin secretion stimulating activity of the gut.
21例轻度成年型糖尿病患者接受十二指肠内输注氨基酸混合物(每千克体重0.5克氨基酸)。另外9例患者静脉输注恒定剂量25克的L-精氨酸。在对照条件下以及在用苯乙双胍治疗三天后(每天150毫克),并在第二次负荷前60分钟给予相同的150毫克剂量后,测定α-氨基氮、血糖和血浆胰岛素水平。十二指肠内输注氨基酸混合物引起的血浆胰岛素升高幅度大于静脉输注L-精氨酸,仅在第一种情况下这种升高被苯乙双胍显著抑制。由于未证明苯乙双胍对氨基酸肠道吸收有明显影响,这种作用可能是由于药物高浓度作用于肠壁的局部作用,导致肠道刺激胰岛素分泌的活性受到抑制。